http://news.bbc.co.uk/hi/english/health/newsid_1550000/1550030.stm
Tuesday, 18 September, 2001, 08:38 GMT 09:38 UK
Vaccine
cuts meningitis cases by 80%

The
introduction of a vaccine for Meningitis C has led to a massive fall in cases
The
number of cases of the deadly brain disease meningitis C have been slashed by
the introduction of a vaccine, experts say.
Scientists at the Public Health Laboratory
Service (PHLS) annual scientific conference in Warwick were due to announce on
Tuesday that cases have dropped by 80%.
There were just 142 cases amongst under 20s
in the year ending in June 2000, compared to 700 in the year to June 1999.
The PHLS figures echo results published in
January which showed a 90% fall in the number of cases in babies under one year
old, and amongst 15 - 17 years old - the first two groups to be vaccinated.
|
We have seen dramatic reductions in cases of the disease
|
|
Dr Mary Ramsay, PHLS |
Britain was the first country to introduce
the vaccine.
Reductions
Dr Mary Ramsay of the PHLS immunisation
division, said, "Since the new vaccine against group C meningococcal
disease was first introduced in November 1999, we have seen dramatic reductions
in cases of the disease amongst those age groups who have been vaccinated.
"As well as demonstrating that the
vaccine is very effective, our surveillance shows that the vaccine also has an
excellent safety record. "
But she said it was still important for
people to remain vigilant for the signs and symptoms of the disease.
There are three strains of meningococcal
meningitis, A, B, and C.
Vaccines are available for both type C and
type A.
Meningitis C accounts for around 40% of
cases.
Scientists are still working on a vaccine for
meningitis B, but it is years away from being publicly available.
Rash
Meningitis is an inflammation of the brain
lining and is mostly caused by bacteria and viruses.
A stiff neck and a purplish rash are key
signs of the disease.
If meningococcal meningitis is caught early,
it can be treated with antibiotics, but it is important to catch the disease
early.
The majority of patients survive, but experts
think around an eighth of patients suffer after-effects.
These include brain damage, loss of sight,
hearing impairments, arthritis, fits, loss of balance, depression and fatigue.
Most of the after-effects disappear after a year.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.